Noemie Van Garderen

Title: The Innovative Contributions of Noemie Van Garderen in Hydroxyapatite Research

Introduction: Noemie Van Garderen is a distinguished inventor based in Dubendorf, Switzerland, with an impressive portfolio of four patents, primarily focused on the innovative production of porous calcium-deficient hydroxyapatite granules. Her research has significant implications for the development of carriers for biologically active substances, particularly proteins, making her contributions invaluable in the fields of biomaterials and biotechnology.

Latest Patents: Noemie’s latest patents revolve around the method of producing porous calcium-deficient hydroxyapatite granules. The process involves several carefully designed steps:

1. Subjecting granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD), or calcium sulfate hemihydrate (CSH) to a first incubation in an alkaline aqueous solution with a pH-value of less than 10 and containing phosphate ions (PO₄^3-).

2. A second incubation is then performed in a higher pH solution.

3. The granules are filtered and dried post incubation.

4. Notably, the sum of phosphate ions present must be significant enough to match the sulfate ions’ amount from the initial granules.

These methods yield porous calcium-deficient hydroxyapatite granules, which have essential applications as carriers for biologically active substances, advancing the knowledge and capabilities within medical and pharmaceutical realms.

Career Highlights: Throughout her career, Noemie Van Garderen has collaborated with noteworthy companies that align with her research interests. Notable organizations include Bioventus, LLC and Mathys Ag Bettlach, where she has applied her expertise in biomaterials and innovative methodologies in her respective fields.

Collaborations: Noemie has collaborated with esteemed colleagues such as Marc Bohner and Howard Seeherman. Their teamwork exemplifies the collaborative spirit essential for driving forward groundbreaking research and innovations in biomaterials.

Conclusion: Noemie Van Garderen's innovative work and patented methods in producing porous calcium-deficient hydroxyapatite granules significantly advance the understanding of biomaterials. Her contributions promise to enhance the development of drug delivery systems and biologically relevant materials, making her a vital figure in contemporary research in these fields.